These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 18381440)

  • 21. WWOX gene expression abolishes ovarian cancer tumorigenicity in vivo and decreases attachment to fibronectin via integrin alpha3.
    Gourley C; Paige AJ; Taylor KJ; Ward C; Kuske B; Zhang J; Sun M; Janczar S; Harrison DJ; Muir M; Smyth JF; Gabra H
    Cancer Res; 2009 Jun; 69(11):4835-42. PubMed ID: 19458077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of ascites-derived ovarian tumor cells from spontaneously occurring ovarian tumors of the chicken: evidence for E-cadherin upregulation.
    Tiwari A; Hadley JA; Hendricks GL; Elkin RG; Cooper T; Ramachandran R
    PLoS One; 2013; 8(2):e57582. PubMed ID: 23460878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formation of E-cadherin-mediated cell-cell adhesion activates AKT and mitogen activated protein kinase via phosphatidylinositol 3 kinase and ligand-independent activation of epidermal growth factor receptor in ovarian cancer cells.
    Reddy P; Liu L; Ren C; Lindgren P; Boman K; Shen Y; Lundin E; Ottander U; Rytinki M; Liu K
    Mol Endocrinol; 2005 Oct; 19(10):2564-78. PubMed ID: 15928314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Wnt11 alters integrin and cadherin expression by ovarian cancer spheroids and inhibits tumorigenesis and metastasis.
    Azimian-Zavareh V; Hossein G; Ebrahimi M; Dehghani-Ghobadi Z
    Exp Cell Res; 2018 Aug; 369(1):90-104. PubMed ID: 29753625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. P-cadherin promotes ovarian cancer dissemination through tumor cell aggregation and tumor-peritoneum interactions.
    Usui A; Ko SY; Barengo N; Naora H
    Mol Cancer Res; 2014 Apr; 12(4):504-13. PubMed ID: 24448686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell adhesion molecule profiles, proliferation activity and p53 expression in advanced epithelial ovarian cancer induced malignant ascites-Correlation of tissue microarray and cytology microarray.
    Toth L; Nagy B; Mehes G; Laszlo E; Molnar PP; Poka R; Hernadi Z
    Pathol Res Pract; 2018 Jul; 214(7):978-985. PubMed ID: 29801775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HER2 mediates epidermal growth factor-induced down-regulation of E-cadherin in human ovarian cancer cells.
    Cheng JC; Qiu X; Chang HM; Leung PC
    Biochem Biophys Res Commun; 2013 Apr; 434(1):81-6. PubMed ID: 23542467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ascites microenvironment conditions the peritoneal pre-metastatic niche to promote the implantation of ovarian tumor spheroids: Involvement of fibrinogen/fibrin and αV and α5β1 integrins.
    Laurent-Issartel C; Landras A; Agniel R; Giffard F; Blanc-Fournier C; Da Silva Cruz E; Habes C; Leroy-Dudal J; Carreiras F; Kellouche S
    Exp Cell Res; 2024 Aug; 441(1):114155. PubMed ID: 39002689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transketolase is upregulated in metastatic peritoneal implants and promotes ovarian cancer cell proliferation.
    Ricciardelli C; Lokman NA; Cheruvu S; Tan IA; Ween MP; Pyragius CE; Ruszkiewicz A; Hoffmann P; Oehler MK
    Clin Exp Metastasis; 2015 Jun; 32(5):441-55. PubMed ID: 25895698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The activated transforming growth factor-beta signaling pathway in peritoneal metastases is a potential therapeutic target in ovarian cancer.
    Yamamura S; Matsumura N; Mandai M; Huang Z; Oura T; Baba T; Hamanishi J; Yamaguchi K; Kang HS; Okamoto T; Abiko K; Mori S; Murphy SK; Konishi I
    Int J Cancer; 2012 Jan; 130(1):20-8. PubMed ID: 21503873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kindlin-2 inhibits serous epithelial ovarian cancer peritoneal dissemination and predicts patient outcomes.
    Ren C; Du J; Xi C; Yu Y; Hu A; Zhan J; Guo H; Fang W; Liu C; Zhang H
    Biochem Biophys Res Commun; 2014 Mar; 446(1):187-94. PubMed ID: 24583125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting eukaryotic elongation factor-2 kinase suppresses the growth and peritoneal metastasis of ovarian cancer.
    Erdogan MA; Ashour A; Yuca E; Gorgulu K; Ozpolat B
    Cell Signal; 2021 May; 81():109938. PubMed ID: 33539938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD44 variant 6 is correlated with peritoneal dissemination and poor prognosis in patients with advanced epithelial ovarian cancer.
    Tjhay F; Motohara T; Tayama S; Narantuya D; Fujimoto K; Guo J; Sakaguchi I; Honda R; Tashiro H; Katabuchi H
    Cancer Sci; 2015 Oct; 106(10):1421-8. PubMed ID: 26250934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peritoneal and hematogenous metastases of ovarian cancer cells are both controlled by the p90RSK through a self-reinforcing cell autonomous mechanism.
    Torchiaro E; Lorenzato A; Olivero M; Valdembri D; Gagliardi PA; Gai M; Erriquez J; Serini G; Di Renzo MF
    Oncotarget; 2016 Jan; 7(1):712-28. PubMed ID: 26625210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The H3K9 methyltransferase G9a is a marker of aggressive ovarian cancer that promotes peritoneal metastasis.
    Hua KT; Wang MY; Chen MW; Wei LH; Chen CK; Ko CH; Jeng YM; Sung PL; Jan YH; Hsiao M; Kuo ML; Yen ML
    Mol Cancer; 2014 Aug; 13():189. PubMed ID: 25115793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. P-cadherin cooperates with insulin-like growth factor-1 receptor to promote metastatic signaling of gonadotropin-releasing hormone in ovarian cancer via p120 catenin.
    Cheung LW; Mak AS; Cheung AN; Ngan HY; Leung PC; Wong AS
    Oncogene; 2011 Jun; 30(26):2964-74. PubMed ID: 21317933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MUC4 mucin-induced epithelial to mesenchymal transition: a novel mechanism for metastasis of human ovarian cancer cells.
    Ponnusamy MP; Lakshmanan I; Jain M; Das S; Chakraborty S; Dey P; Batra SK
    Oncogene; 2010 Oct; 29(42):5741-54. PubMed ID: 20697346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cadherin switching in ovarian cancer progression.
    Patel IS; Madan P; Getsios S; Bertrand MA; MacCalman CD
    Int J Cancer; 2003 Aug; 106(2):172-7. PubMed ID: 12800191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of α5-integrin, α7-integrin, Ε-cadherin, and N-cadherin in localized prostate cancer.
    Drivalos A; Chrisofos M; Efstathiou E; Kapranou A; Kollaitis G; Koutlis G; Antoniou N; Karanastasis D; Dimopoulos MA; Bamias A
    Urol Oncol; 2016 Apr; 34(4):165.e11-8. PubMed ID: 26652134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Binding of endostatin to human ovarian cancer cells inhibits cell attachment.
    Yokoyama Y; Ramakrishnan S
    Int J Cancer; 2007 Dec; 121(11):2402-9. PubMed ID: 17597104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.